Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Graft vs. Host Disease (GvHD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03233659
What this trial is testing

Immune Monitoring After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Allogeneic Stem Cell TransplantationGVHD
IRCCS Azienda Ospedaliero-Universitaria di Bologna 177
Testing effectiveness (Phase 2)Looking for participantsNCT06199427
What this trial is testing

PTCy and and Ruxolitinib for GVHD Prophylaxis After HSCT With Thymoglobulin in Conditioning Regimen in Patients With Inborn Errors of Immunity

Who this might be right for
Inborn Errors of Immunity
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 100
Large-scale testing (Phase 3)Study completedNCT00210860
What this trial is testing

An Open Label Extension of a Study Comparing Topiramate and Amitriptyline in Migraine Prevention.

Who this might be right for
Migraine
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 142
Testing effectiveness (Phase 2)Study completedNCT00346359
What this trial is testing

Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+2 more
Fred Hutchinson Cancer Center 40
Testing effectiveness (Phase 2)Ended earlyNCT01475162
What this trial is testing

Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease

Who this might be right for
Acute Graft Versus Host Disease
Medical College of Wisconsin 14
Large-scale testing (Phase 3)Looking for participantsNCT02416388
What this trial is testing

Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR

Who this might be right for
Acute Myeloid Leukemia (AML)
University Hospital, Angers 3,100
Testing effectiveness (Phase 2)UnknownNCT00314483
What this trial is testing

Evaluation of the Role of Mesenchymal Stem Cells in the Treatment of Graft Versus Host Disease

Who this might be right for
Graft vs Host Disease
Christian Medical College, Vellore, India 25
Large-scale testing (Phase 3)Looking for participantsNCT07047456
What this trial is testing

Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies Post UCBT

Who this might be right for
Acute Graft Versus Host Disease
Anhui Provincial Hospital 134
Testing effectiveness (Phase 2)Study completedNCT00626522
What this trial is testing

Aclidinium/Formoterol Fixed Combination Dose Finding Study

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca 808
Not applicableNot Yet RecruitingNCT07689786
What this trial is testing

Effects of Using Miswak in Addition to Oral Hygiene Products in Patients With Gingivitis

Who this might be right for
Gingivitis; Chronic
Mustafa Kemal University 36
Early research (Phase 1)UnknownNCT05352269
What this trial is testing

Safety and Tolerability of FMT Capsules in Healthy Volunteers

Who this might be right for
Acute-graft-versus-host Disease
Shenzhen Xbiome Biotech Co., Ltd. 36
Testing effectiveness (Phase 2)Study completedNCT02891395
What this trial is testing

Efficacy and Safety of Nilotinib in Patients With a Chronic Disease of the Graft Against the Host

Who this might be right for
Graft Versus Host Disease
University Hospital, Lille 65
Not applicableNot Yet RecruitingNCT06759675
What this trial is testing

Comparative Effects of Group Based Exercises with and Without Cognitive Functional Therapy on Clinical Outcomes in Patients with Chronic Low Back Pain

Who this might be right for
Low Back Pain, Chronic
University of Faisalabad 40
Testing effectiveness (Phase 2)Ended earlyNCT01044745
What this trial is testing

Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+108 more
University of Nebraska 20
Large-scale testing (Phase 3)Study completedNCT00210912
What this trial is testing

The Effectiveness and Safety of Topiramate Versus Placebo for Preventing Chronic Migraine Headaches

Who this might be right for
Migraine
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 328
Not applicableStudy completedNCT00003538
What this trial is testing

Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not applicableStudy completedNCT04460118
What this trial is testing

Clinical and Radiographic Outcomes in Arthroscopic "Inlay"Bristow Surgery With Screw Fixation vs Suture-button Fixation

Who this might be right for
Shoulder; Dislocation, Chronic
Peking University Third Hospital 117
Not applicableEnded earlyNCT03102060
What this trial is testing

Gluten Free Diet in Preventing Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplant

Who this might be right for
Graft Versus Host DiseaseHematopoietic Cell Transplantation Recipient
Rutgers, The State University of New Jersey 7
Testing effectiveness (Phase 2)UnknownNCT01765660
What this trial is testing

Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-versus-host Disease

Who this might be right for
Chronic Graft-versus-host Disease
Nanfang Hospital, Southern Medical University 60
Testing effectiveness (Phase 2)Ended earlyNCT00548717
What this trial is testing

Sirolimus, Mycophenolate Mofetil and Bortezomib as Graft-Versus-Host Disease (GVHD) Prophylaxis After Reduced Intensity Conditioning (RIC) Hematopoietic Stem Cell Transplantation

Who this might be right for
Graft-vs-Host Disease
Dana-Farber Cancer Institute 15
Next Page